Supplement for "Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study"

Name: Supplement for "Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study"
Creator: Manabu Oda
Published: 2022-04-06T16:56:47.719Z
Keywords: Clinical Trial, Pediatric Dermatology, Atopic Dermatitis, Eczema, Topical Treatment, Pruritus, Janus Kinase

Oda, Manabu

doi:10.17632/6yrdmwydzj.2

Supplement for "Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study"

Published: 6 April 2022| Version 2 | DOI: 10.17632/6yrdmwydzj.2

Contributor:

Manabu Oda

Description

Supplementary Information and Results - Nakagawa H, et al. Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study. Change in Version 2: - Correction of the values of "Expose duration" in Supplementary Table I

Supplement for "Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study"

Description

Files

Categories

Licence